宮田遥 (Haruka Miyata) - マイポータル

基本情報

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.

Haruka Miyata, Yoshihiko Hirohashi, Shuhei Yamada, Junko Yanagawa, Aiko Murai, Shinichi Hashimoto, Serina Tokita, Kanta Hori, Takashige Abe, Terufumi Kubo …

Cancer immunology, immunotherapy : CII 71(4) 795-806 2022年4月
Abscopal effect following nivolumab induction in a patient with metastatic renal cell carcinoma-unique pathological features of the primary specimen: A case report.

Kanta Hori, Yoshihiko Hirohashi, Toshiki Aoyagi, Narumi Taniguchi, Masashi Murakumo, Haruka Miyata, Toshihiko Torigoe, Takashige Abe, Nobuo Shinohara, Ken Morita

Experimental and therapeutic medicine 19(3) 1903-1907 2020年3月

泌尿器癌における腫瘍血管内皮細胞の役割

菊地央, 菊地央, 山田修平, 古御堂純, 古御堂純, 宮田遥, 松本隆児, 大澤崇宏, 大澤崇宏, 秋野文臣 …

日本泌尿器科学会総会(Web) 108th 500-500 2020年
RENAL NEPHROMETRY SCORE CORRELATED WITH TUMOR PROLIFERATIVE ACTIVITY OF T1 CLEAR CELL RENAL CELL CARCINOMA

Hiroshi Kikuchi, Takashige Abe, Ryuji Matsumoto, Jun Furumido, Haruka Miyata, Takahiro Osawa, Sachiyo Murai, Nobuo Shinohara

JOURNAL OF UROLOGY 201(4) E274-E275 2019年4月